US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
EP1058549A4
(fr)
*
|
1998-12-23 |
2003-11-12 |
Bristol Myers Squibb Pharma Co |
INHIBITEURS DU FACTEUR Xa OU DE LA THROMBINE
|
DK1159279T3
(da)
|
1999-03-09 |
2003-02-17 |
Upjohn Co |
4-Oxo-4,7-dihydro-thieno[2,3-b]pyridin-5-carboxamider som antivirale midler
|
WO2000075145A1
(fr)
*
|
1999-06-03 |
2000-12-14 |
Abbott Laboratories |
Composes anti-inflammatoires inhibant l'adhesion cellulaire
|
SI1194425T1
(sl)
*
|
1999-06-23 |
2005-12-31 |
Sanofi Aventis Deutschland |
Substituirani benzimidazoli
|
US6689883B1
(en)
|
1999-09-28 |
2004-02-10 |
Bayer Pharmaceuticals Corporation |
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
|
JP2003522759A
(ja)
*
|
2000-02-09 |
2003-07-29 |
ザ プロクター アンド ギャンブル カンパニー |
2−カルボキサミド−ベンズイミダゾール類
|
US7977333B2
(en)
|
2000-04-20 |
2011-07-12 |
Bayer Healthcare Llc |
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
|
EA007339B1
(ru)
|
2001-07-27 |
2006-08-25 |
Кьюэрис, Инк. |
Медиаторы путей передачи сигналов генами hedgehog, содержащие их композиции и способы применения указанных веществ
|
BR0211214A
(pt)
|
2001-08-30 |
2004-07-13 |
Upjohn Co |
4-tioxo-4,7-dihidro-tieno [2,3-b]piridina-5-carboxamidas como agentes antivirais
|
WO2003020728A1
(fr)
|
2001-08-30 |
2003-03-13 |
Pharmacia & Upjohn Company |
Agents antiviraux a base de 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carbothioamides
|
AR038294A1
(es)
|
2002-01-14 |
2005-01-12 |
Upjohn Co |
Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales
|
AR038118A1
(es)
|
2002-01-14 |
2004-12-29 |
Upjohn Co |
Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales
|
AR038117A1
(es)
|
2002-01-14 |
2004-12-29 |
Upjohn Co |
Agentes antivirales derivados de la 4- oxo-4,7 -dihidrofuro [2,3-b]piridin-5-carboxamida
|
AU2003299472A1
(en)
|
2002-05-06 |
2004-07-22 |
Vertex Pharmaceuticals Incorporated |
Thiadiazoles or oxadiazoles and their use as inhibitors of JAK kinase
|
EP1537112B1
(fr)
|
2002-08-06 |
2006-04-19 |
Astrazeneca AB |
Pyridines condensees et pyrimidines a activite tie2 (tek)
|
IL154306A0
(en)
*
|
2003-02-05 |
2003-09-17 |
Rimonyx Pharmaceuticals Ltd |
Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof
|
MXPA06012682A
(es)
*
|
2004-05-04 |
2007-01-16 |
Hoffmann La Roche |
Tienopiridinas como inhibidores ikk.
|
JP2007536301A
(ja)
*
|
2004-05-04 |
2007-12-13 |
エフ.ホフマン−ラ ロシュ アーゲー |
Ikk阻害剤としてのチエノピリダジン
|
US20060074102A1
(en)
*
|
2004-05-14 |
2006-04-06 |
Kevin Cusack |
Kinase inhibitors as therapeutic agents
|
RU2007101509A
(ru)
|
2004-06-17 |
2008-07-27 |
Уайт (Us) |
Способ получения антагонистов рецепторов гормона, высвобождающего гонадотропин
|
JP2008503469A
(ja)
|
2004-06-17 |
2008-02-07 |
ワイス |
ゴナドトロピン放出ホルモン受容体アンタゴニスト
|
RU2007107167A
(ru)
|
2004-07-30 |
2008-09-10 |
Метилджин, Инк. (Ca) |
Ингибиторы передачи сигнала рецептора vegf и рецептора hgf
|
AR050365A1
(es)
|
2004-08-02 |
2006-10-18 |
Osi Pharm Inc |
Compuestos inhibidores de multi- quinasa pirrolopirimidina aril- amino sustituidos.
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
CN101084224B
(zh)
*
|
2004-10-21 |
2013-12-04 |
美国陶氏益农公司 |
具有杀真菌活性的噻吩并-嘧啶化合物
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
US7674822B2
(en)
|
2004-11-24 |
2010-03-09 |
Wyeth |
PTP1b inhibitors
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
US7582634B2
(en)
|
2005-02-18 |
2009-09-01 |
Wyeth |
7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
|
US7538113B2
(en)
|
2005-02-18 |
2009-05-26 |
Wyeth |
4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
|
US7534796B2
(en)
|
2005-02-18 |
2009-05-19 |
Wyeth |
Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
|
US7531542B2
(en)
|
2005-05-18 |
2009-05-12 |
Wyeth |
Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
|
ES2623221T3
(es)
|
2005-05-20 |
2017-07-10 |
Methylgene Inc |
Inhibidores de la señalización del receptor de VEGF y del receptor de HGF
|
KR101078968B1
(ko)
|
2005-05-20 |
2011-11-01 |
메틸진 인코포레이티드 |
Vegf 수용체 및 hgf 수용체 신호전달 억제제
|
US7582636B2
(en)
|
2005-05-26 |
2009-09-01 |
Wyeth |
Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
|
CN102127078A
(zh)
|
2005-07-14 |
2011-07-20 |
安斯泰来制药株式会社 |
Janus激酶3的杂环类抑制剂
|
EP1910358A2
(fr)
|
2005-07-14 |
2008-04-16 |
Astellas Pharma Inc. |
Heterocycles inhibiteurs de janus kinase-3
|
WO2007022947A2
(fr)
|
2005-08-21 |
2007-03-01 |
Abbott Gmbh & Co. Kg |
Composes 5-cycle-heteroaromates et leur utilisation en tant que partenaires de liaison des recepteurs 5-ht5
|
CA2621261C
(fr)
|
2005-09-22 |
2014-05-20 |
Incyte Corporation |
Inhibiteurs tetracycliques de janus kinases
|
CN103214483B
(zh)
|
2005-12-13 |
2014-12-17 |
因塞特公司 |
作为两面神激酶抑制剂的杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]嘧啶
|
TWI417095B
(zh)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
|
DK3421471T3
(da)
|
2006-04-25 |
2021-06-14 |
Astex Therapeutics Ltd |
Purin- og deazapurinderivater som farmaceutiske forbindelser
|
US8227603B2
(en)
|
2006-08-01 |
2012-07-24 |
Cytokinetics, Inc. |
Modulating skeletal muscle
|
US8299248B2
(en)
|
2006-08-02 |
2012-10-30 |
Cytokinetics, Incorporated |
Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
|
ES2558517T3
(es)
|
2006-08-02 |
2016-02-04 |
Cytokinetics, Inc. |
Ciertas entidades químicas, composiciones y métodos que comprenden imidazopirimidinas
|
ES2415863T3
(es)
|
2006-12-22 |
2013-07-29 |
Incyte Corporation |
Heterociclos sustituidos como inhibidores de Janus Quinasas
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
US7851484B2
(en)
|
2007-03-30 |
2010-12-14 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
EP2740731B1
(fr)
|
2007-06-13 |
2016-03-23 |
Incyte Holdings Corporation |
Sels cristallines de l'inhibiteur de janus kinase (r)-3-(4- (7h-pyrrolo [2,3-d] pyrimidin-4-yl)-1h-pyrazol-1-yl) -3-cyclopentylpropanenitrile
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
US9114138B2
(en)
|
2007-09-14 |
2015-08-25 |
Janssen Pharmaceuticals, Inc. |
1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones
|
EA019085B1
(ru)
|
2007-09-14 |
2014-01-30 |
Янссен Фармасьютикалз, Инк. |
1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны
|
SI2201012T1
(sl)
|
2007-10-11 |
2014-10-30 |
Astrazeneca Ab |
Derivati pirolo(2,3-D)pirimidina kot inhibitorji proteina kinaze B
|
MX2010005300A
(es)
|
2007-11-16 |
2010-06-25 |
Incyte Corp |
4-pirazolil-n-arilpirimidin-2-aminas y 4-pirazolil-n-heteroarilpir imidin-2-aminas como inhibidores de cinasas janus.
|
JP4719317B2
(ja)
|
2008-02-26 |
2011-07-06 |
武田薬品工業株式会社 |
縮合複素環誘導体およびその用途
|
SG182146A1
(en)
|
2008-03-05 |
2012-07-30 |
Methylgene Inc |
Inhibitors of protein tyrosine kinase activity
|
DK2288610T3
(en)
|
2008-03-11 |
2016-11-28 |
Incyte Holdings Corp |
Azetidinesulfonic AND CYCLOBUTANDERIVATER AS JAK INHIBITORS
|
CA2722326A1
(fr)
|
2008-04-24 |
2009-10-29 |
Incyte Corporation |
Composes macrocycliques et leur utilisation a titre d'inhibiteurs de kinase
|
WO2010025890A1
(fr)
|
2008-09-02 |
2010-03-11 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc |
Dérivés de 3-azabicyclo[3.1.0]hexyle comme modulateurs des récepteurs métabotropiques du glutamate
|
AU2009319387B2
(en)
|
2008-11-28 |
2012-05-10 |
Addex Pharma S.A. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
US8765727B2
(en)
|
2009-01-23 |
2014-07-01 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
JP5634506B2
(ja)
|
2009-05-12 |
2014-12-03 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド |
1,2,3−トリアゾロ[4,3−a]ピリジン誘導体ならびに神経障害および精神障害の治療または予防のためのその使用
|
CA2760259C
(fr)
|
2009-05-12 |
2018-05-01 |
Janssen Pharmaceuticals, Inc. |
Derives de la 1,2,4-triazolo [4,3-a] pyridine et leur utilisation en tant que modulateurs allosteriques positifs des recepteurs mglur2
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
BRPI1012159B1
(pt)
|
2009-05-22 |
2022-01-25 |
Incyte Holdings Corporation |
Compostos derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d] pirimidinas e pirrol-3-il-pirrolo[2,3-d] pirimidinas como inibidores de janus cinase, composições farmacêuticas compreendendo os referidos compostos e usos dos mesmos
|
DK2432472T3
(da)
|
2009-05-22 |
2019-11-18 |
Incyte Holdings Corp |
3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octan- eller heptan-nitril som jak-inhibitorer
|
US9096518B2
(en)
|
2009-06-22 |
2015-08-04 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
US8624040B2
(en)
|
2009-06-22 |
2014-01-07 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
TW201113285A
(en)
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
PT2486041E
(pt)
|
2009-10-09 |
2013-11-14 |
Incyte Corp |
Derivados hidroxilo, ceto e glucuronido de 3-(4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)-3-ciclopentil-propanonitrilo
|
KR102283091B1
(ko)
|
2010-03-10 |
2021-07-30 |
인사이트 홀딩스 코포레이션 |
Jak1 저해제로서의 피페리딘4일 아제티딘 유도체
|
EP2574168B9
(fr)
|
2010-05-21 |
2016-10-05 |
Incyte Holdings Corporation |
Formulation topique pour inhibiteur de jak
|
CN102260270A
(zh)
*
|
2010-05-28 |
2011-11-30 |
中国科学院上海药物研究所 |
N-(2-甲基呋喃[2,3-d]嘧啶-4-基)丙烯酰胺、其制备方法及其用途
|
ES2552455T3
(es)
|
2010-11-08 |
2015-11-30 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
JP5852666B2
(ja)
|
2010-11-08 |
2016-02-03 |
ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド |
1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
|
JP5852665B2
(ja)
|
2010-11-08 |
2016-02-03 |
ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド |
1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
|
AR083933A1
(es)
|
2010-11-19 |
2013-04-10 |
Incyte Corp |
Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
|
JP5917544B2
(ja)
|
2010-11-19 |
2016-05-18 |
インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation |
Jak阻害剤としての複素環置換ピロロピリジンおよびピロロピリミジン
|
WO2012088015A2
(fr)
|
2010-12-22 |
2012-06-28 |
Millennium Pharmaceuticals, Inc. |
Acides hydroxamiques substitués et leurs utilisations
|
PT2675451E
(pt)
|
2011-02-18 |
2015-10-16 |
Incyte Corp |
Terapia de combinação com inibidores mtor/jak
|
DK2694056T3
(da)
|
2011-04-01 |
2020-01-02 |
Astrazeneca Ab |
Terapeutisk behandling
|
CN103797010B
(zh)
|
2011-06-20 |
2016-02-24 |
因塞特控股公司 |
作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物
|
BR112014000314A2
(pt)
|
2011-07-08 |
2017-01-10 |
Novartis Ag |
derivados de pirrolo pirimidina
|
EA028060B1
(ru)
|
2011-07-13 |
2017-10-31 |
Сайтокинетикс, Инк. |
Комбинированная терапия бокового амиотрофического склероза
|
CA2844507A1
(fr)
|
2011-08-10 |
2013-02-14 |
Novartis Pharma Ag |
Polytherapie par jak pi3k/mtor
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
MY175800A
(en)
|
2011-11-30 |
2020-07-09 |
Astrazeneca Ab |
Combination treatment of cancer
|
ES2963218T3
(es)
|
2011-12-28 |
2024-03-25 |
Global Blood Therapeutics Inc |
Productos intermedios para obtener compuestos de benzaldehído sustituidos y métodos para su uso en el aumento de la oxigenación tisular
|
WO2013102145A1
(fr)
|
2011-12-28 |
2013-07-04 |
Global Blood Therapeutics, Inc. |
Composés d'aldéhydes hétéroaryles substitués et leurs procédés d'utilisation dans l'accroissement de l'oxygénation tissulaire
|
AU2013204533B2
(en)
|
2012-04-17 |
2017-02-02 |
Astrazeneca Ab |
Crystalline forms
|
US9193733B2
(en)
|
2012-05-18 |
2015-11-24 |
Incyte Holdings Corporation |
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
CR20190073A
(es)
|
2012-11-15 |
2019-04-25 |
Incyte Holdings Corp |
FORMAS DE DOSIFICACIÓN DE RUXOLITINIB DE LIBERACIÓN SOTENIDA (Divisional 2015-265)
|
RS62867B1
(sr)
|
2013-03-06 |
2022-02-28 |
Incyte Holdings Corp |
Postupci i intermedijeri za dobijanje inhibitora jak
|
CA2902711C
(fr)
|
2013-03-15 |
2021-07-06 |
Global Blood Therapeutics, Inc. |
Derives de pyridinyl-6-methoxy-2-hydroxybenzaldehyde substitues et compositions pharmaceutiques de ceux-ci pour utilisation dans la modulation de l'hemoglobine
|
US9422279B2
(en)
|
2013-03-15 |
2016-08-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US9604999B2
(en)
|
2013-03-15 |
2017-03-28 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
WO2014145040A1
(fr)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Composés aldéhydes substitués et leurs procédés d'utilisation pour accroître l'oxygénation tissulaire
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US20160083343A1
(en)
|
2013-03-15 |
2016-03-24 |
Global Blood Therapeutics, Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
CN111454200A
(zh)
|
2013-03-15 |
2020-07-28 |
全球血液疗法股份有限公司 |
化合物及其用于调节血红蛋白的用途
|
US20140274961A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
EP3030227B1
(fr)
|
2013-08-07 |
2020-04-08 |
Incyte Corporation |
Formes galéniques à libération prolongée pour un inhibiteur jak1
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
EA201992707A1
(ru)
|
2013-11-18 |
2020-06-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
DK3071206T3
(da)
|
2013-11-22 |
2021-05-25 |
CL BioSciences LLC |
Gastrinantagonister (eg yf476, netazepid) til behandling og forebyggelse af osteoporose
|
WO2015110435A1
(fr)
|
2014-01-21 |
2015-07-30 |
Janssen Pharmaceutica Nv |
Combinaisons comprenant des modulateurs allostériques positifs ou des agonistes orthostériques de sous-type 2 de récepteur glutamatergique métabotrope, et leur utilisation
|
LT3096790T
(lt)
|
2014-01-21 |
2019-10-10 |
Janssen Pharmaceutica, N.V. |
Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas
|
CA2916564C
(fr)
|
2014-02-07 |
2023-02-28 |
Global Blood Therapeutics, Inc. |
Polymorphes cristallins de la base libre de 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|
MA41841A
(fr)
|
2015-03-30 |
2018-02-06 |
Global Blood Therapeutics Inc |
Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
|
SG10201912511WA
(en)
|
2015-12-04 |
2020-02-27 |
Global Blood Therapeutics Inc |
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
TWI663160B
(zh)
|
2016-05-12 |
2019-06-21 |
全球血液治療公司 |
用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
|
CN107513067A
(zh)
|
2016-06-16 |
2017-12-26 |
北京赛林泰医药技术有限公司 |
含有取代环戊基的吡咯并嘧啶化合物
|
US10154992B2
(en)
*
|
2016-07-12 |
2018-12-18 |
The Regents Of The University Of California |
Compounds and methods for treating HIV infection
|
JOP20190024A1
(ar)
|
2016-08-26 |
2019-02-19 |
Gilead Sciences Inc |
مركبات بيروليزين بها استبدال واستخداماتها
|
TWI778983B
(zh)
|
2016-10-12 |
2022-10-01 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
AR113922A1
(es)
|
2017-12-08 |
2020-07-01 |
Incyte Corp |
Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas
|
PE20211310A1
(es)
|
2018-01-30 |
2021-07-22 |
Incyte Corp |
Procedimiento para la elaboracion de un recipiente de vidrio de sosa-cal a partir de materiales formadores de vidrio 100% reciclados y un recipiente de vidrio elaborado a partir de dicho procedimiento
|
KR102526964B1
(ko)
|
2018-02-26 |
2023-04-28 |
길리애드 사이언시즈, 인코포레이티드 |
Hbv 복제 억제제로서의 치환된 피롤리진 화합물
|
JP2021519775A
(ja)
|
2018-03-30 |
2021-08-12 |
インサイト・コーポレイションIncyte Corporation |
Jak阻害剤を用いる化膿性汗腺炎の治療
|
US11014884B2
(en)
|
2018-10-01 |
2021-05-25 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin
|
AR117472A1
(es)
|
2018-12-21 |
2021-08-11 |
Celgene Corp |
Inhibidores de tienopiridina de ripk2
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|